Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine · 29.03.2023 · 12 (7) · 2586
DOI: 10.3390/jcm12072586 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.03.2023. Verfasst von Onorina Berardicurti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portill…. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulmonary lung involvement is the most common extra-glandular manifestation in patients with primary Sjögren’s syndrome (pSS), leading to a worsening of the patient’s prognosis. To date, different studies have assessed the prevalence of pulmonary involvement and interstitial lung disease (ILD) in pSS patients with different results.
Methods
We performed a systematic literature review and meta-analysis on ILD pooled prevalence in pSS according to the PRISMA and MOOSE guidelines. Furthermore, we explored the pooled prevalence of the two main presentations of pSS-ILD, nonspecific interstitial pneumonia (NSIP) and usual interstitial pneumonia (UIP).
Results
We analysed the pSS-ILD prevalence in 30 studies including 8255 pSS patients. The pSS-ILD pooled prevalence was 23% (95% CI: 16–30). For NSIP, we found a pooled prevalence of 52% (CI 41–64), and for UIP we found a pooled prevalence of 44% (CI: 32–55). Regarding the meta-regression analysis, male gender, DLco value, country, and HRCT seem to contribute to the ILD presence.
Conclusions
At least 20% of pSS patients have a comorbid ILD, usually NSIP. Male gender and alteration in DLco value may be considered the most important independent factors supporting an active search of lung complications during the clinical history of pSS patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical and Research Section of Rheumatology and Clinical Immunology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.
- Rheumatology and Clinical Immunology, Department of Medicine, School of Medicine, University of Rome "Campus Bio-Medico", 00128 Rome, Italy.
- Endocrinology Outpatient Clinic, ASL Avezzano-Sulmona-L'Aquila, 67039 Sulmona, Italy.
ORCID-Profile: Onorina Berardicurti
Zitieren
APA
Berardicurti, O., Marino, A., Genovali, I., Navarini, L., D'Andrea, S., Currado, D., Rigon, A., Arcarese, L., Vadacca, M., & Giacomelli, R. (2023). Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 12(7), 2586. https://doi.org/10.3390/jcm12072586
Vancouver
Berardicurti O, Marino A, Genovali I, Navarini L, D'Andrea S, Currado D, et al. Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2023;12(7):2586. doi:10.3390/jcm12072586
BibTeX
@article{Berardicurti2023,
author = {Berardicurti, Onorina and Marino, Annalisa and Genovali, Irene and Navarini, Luca and D'Andrea, Settimio and Currado, Damiano and Rigon, Amelia and Arcarese, Luisa and Vadacca, Marta and Giacomelli, Roberto},
title = {Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren’s Syndrome: A Systematic Review and Meta-Analysis},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {7},
pages = {2586},
doi = {10.3390/jcm12072586}
}
EUVIMED